in the US are due to
cardiovascular (CV) disease.

OVER 100million

American ADULTS are living with some form of CV disease or the debilitating effects of stroke.1

45%of the US

population is estimated to have CV disease by 2035.3

Are we doing enough to protect our hearts?


Americans have high cholesterol, a common risk factor for CV disease. And that's just one of many causes.1,4


Cardiovascular disease is the number one killer of women and men, and your risk may begin to increase once you are over 45.5-7


living with high cholesterol, diabetes, and even coronary heart disease have turned to statins.8,9


is how much statins reduce your odds of a life-threatening CV event. Statins, along with diet and exercise, are the first step—but they don’t fully protect you from a serious heart attack or stroke. Persistent CV Risk (P-CVR) is the serious threat of a life-threatening event that remains.10

It's clear that heart disease is too risky to leave to unproven products. Proven treatment on top of cholesterol management is necessary.11

Millions of patients at risk of heart attack or stroke may be unknowingly receiving medications that have not shown to reduce CV risk on top of statins.12,13

If you have been prescribed a fenofibrate—know that fenofibrates are not proven or FDA approved to reduce CV risk on top of statins.13,14

Talk to your doctor about whether switching off of fenofibrates and onto FDA-approved therapies is right for you, as you may still be at risk of having a heart attack or stroke.13,14

It's time to take on persistent CV risk with proven therapies

See what fenofibrates & niacin are missing

See what fish oil supplements lack


if you are a healthcare professional

Click here to see the commercial.

Full Reference List |Disclaimer | Privacy Policy

The Amarin logo is a registered trademark of the Amarin group of companies. All other trademarks are the property of their respective companies.

© 2021 Amarin Pharma, Inc. Bridgewater, NJ, USA.
All rights reserved.
Contact Us: 1-855-CVTRUTH
The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other social media sites.
AMRN-00373v6   06/21